NT-proBNP independently predicts long term mortality after acute exacerbation of COPD – a prospective cohort study
<p>Abstract</p> <p>Background</p> <p>Cardiovascular disease is prevalent and frequently unrecognized in patients with chronic obstructive pulmonary disease (COPD). NT-proBNP is an established risk factor in patients with heart failure. NT-proBNP may also be released fro...
Main Authors: | Høiseth Arne, Omland Torbjørn, Hagve Tor-Arne, Brekke Pål H, Søyseth Vidar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://respiratory-research.com/content/13/1/97 |
Similar Items
-
Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01) -
NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
by: Stefano Ciardullo, et al.
Published: (2022-11-01) -
The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic
by: Lucian MURESAN, et al.
Published: (2017-06-01) -
Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
by: Lise Legrand, et al.
Published: (2020-05-01) -
Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)